特应性皮炎何时需要系统治疗:国际湿疹委员会专家小组建议
国际湿疹委员会专家小组针对特应性皮炎(AD)系统治疗的启动时机与评估框架形成共识建议。建议在系统治疗前系统评估严重程度、生活质量影响,并排除替代诊断、避免触发因素、优化局部治疗、充分教育、治疗感染及考虑光疗。强调决策需结合患者整体健康状况、心理需求及对系统治疗的意愿。
要点
- 系统治疗前应系统评估AD严重程度及对生活质量的影响。
- 启动前需排除替代诊断、避免触发因素、优化局部治疗并治疗感染。
- 决策应结合患者整体健康、心理需求及个人治疗意愿。
核心结论
- 启动系统治疗的决定应基于严重程度和生活质量评估,并考虑患者整体健康、心理需求及对系统治疗的个人态度。
研究设计与样本
- 国际湿疹委员会专家小组共识声明,非系统综述;由专家分组进行专题文献回顾并参考现有指南提供解读。
主要发现
- 建议对严重体征和症状及生活质量影响进行系统整体评估后再启动系统治疗。
- 启动前步骤包括考虑替代或共存诊断、避免触发因素、优化局部治疗、确保患者/照护者教育、治疗共存感染、评估生活质量影响及考虑光疗。
关键数值与推荐
- 推荐条款:系统治疗前应评估AD严重程度及对生活质量的影响。
- 推荐条款:启动前需考虑替代或共存诊断、避免触发因素、优化局部治疗、确保充分教育、治疗共存感染及考虑光疗。
临床怎么用
- 临床中对AD患者启动系统治疗前,应按共识步骤完成全面评估和优化管理。
- 决策时需个体化考虑患者整体健康状况、心理需求及对系统治疗的意愿。
局限性
- 本工作为共识声明,非系统综述。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Although most patients with atopic dermatitis (AD) are effectively managed with topical medication, a significant minority require systemic therapy. Guidelines for decision making about advancement to systemic therapy are lacking. OBJECTIVE: To guide those considering use of systemic therapy in AD and provide a framework for evaluation before making this therapeutic decision with the patient. METHODS: A subgroup of the International Eczema Council determined aspects to consider before prescribing systemic therapy. Topics were assigned to expert reviewers who performed a topic-specific literature review, referred to guidelines when available, and provided interpretation and expert opinion. RESULTS: We recommend a systematic and holistic approach to assess patients with severe signs and symptoms of AD and impact on quality of life before systemic therapy. Steps taken before commencing systemic therapy include considering alternate or concomitant diagnoses, avoiding trigger factors, optimizing topical therapy, ensuring adequate patient/caregiver education, treating coexistent infection, assessing the impact on quality of life, and considering phototherapy. LIMITATIONS: Our work is a consensus statement, not a systematic review. CONCLUSION: The decision to start systemic medication should include assessment of severity and quality of life while considering the individual's general health status, psychologic needs, and personal attitudes toward systemic therapies.
引用
- Simpson EL, Bruin-Weller M, Flohr C, et al. When does atopic dermatitis warrant systemic therapy? Recommendations from an expert panel of the International Eczema Council. J Am Acad Dermatol. 2017. PMID: 28803668. doi:10.1016/j.jaad.2017.06.042
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。